News

The FDA has approved a 200 mg/mL autoinjector of belimumab (Benlysta) for at-home subcutaneous use in children aged 5 years ...
Circular rashes may be puzzling—and alarming. The instant most individuals catch sight of a circle or ring-shaped area on the ...
Word In Black According to Dr. Keith Elkon, lupus impacts Black women at three times the rate of white women, and ...
PHILADELPHIA, PA, USA I June 24, 2025 I GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg/mL ...
Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...
Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.
New research by Swansea University and Cambridge University has revealed the causes and devastating impacts of delays—that ...
New research by Swansea University and the University of Cambridge has revealed the causes and devastating impacts of delays – that can last decades - in diagnosing lupus, an auto-immune condition.